Clinical features of H1N1 2009 infection in critically ill immunocompromised patients

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Camous, Laurent ^a,b   Lemiale, Virginie ^a,b   Canet, Emmanuel ^a,b   Max, Adeline ^a,b   Schnell, David ^a,b   Le Goff, Jerome ^a,b   Rabbat, Antoine ^c   Schlemmer, Benoit ^a,b   Azoulay, Élie ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CEPHALOSPORIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID;

2009 H1N1 INFLUENZA; ARTIFICIAL VENTILATION; BONE MARROW TRANSPLANTATION; CELL MEDIATED CYTOTOXICITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CRITICAL ILLNESS; DISEASE COURSE; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTOPENIA; MANTLE CELL LYMPHOMA; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NOTE; PANDEMIC; PRIORITY JOURNAL; RISK FACTOR; SEASONAL INFLUENZA; STEROID THERAPY; SUPERINFECTION; VIRUS SHEDDING; ARTICLE; IMMUNOLOGY; INFLUENZA; PATHOPHYSIOLOGY;

CRITICAL ILLNESS; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 78149234559     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8927     Document Type: Note

References (5)

1. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007, 357:2601-2614. 10.1056/NEJMra064928, 18094380.
2. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302:1872-1879. 10.1001/jama.2009.1496, 19822627.
3. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, . California Pandemic (H1N1) Working Group Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902. 10.1001/jama.2009.1583, 19887665, California Pandemic (H1N1) Working Group.
4. Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M. ANZIC Influenza Investigators Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361:1925-1934. 10.1056/NEJMoa0908481, 19815860, ANZIC Influenza Investigators.
5. Vilchez RA, McCurry K, Dauber J, Lacono A, Griffith B, Fung J, Kusne S. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002, 2:287-291. 10.1034/j.1600-6143.2002.20315.x, 12096793.